New Jersey · 2026-2027 Regular Session · Bill

A 1510: Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*

In committee Last action June 4, 2026: Reported out of Assembly Comm. with Amendments, 2nd Reading

Plain-language summary

A 1510 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*. Primary sponsor: Roy Freiman (Democratic), Sterley Stanley (Democratic). Most recent recorded action (June 4, 2026): Reported out of Assembly Comm. with Amendments, 2nd Reading.

Sponsors

Primary sponsors: Roy Freiman (Democratic); Sterley Stanley (Democratic).